GeneTx Biotherapeutics
Downers Grove
About GeneTx Biotherapeutics
GeneTx Biotherapeutics is a biotechnology company focusing on developing therapeutics for the treatment of Angelman syndrome. It also offers an antisense therapy for treating the rare genetic disorder that causes developmental delay, impaired motor function, loss of speech, and epilepsy. Founded in 2017, GeneTx Biotherapeutics is headquartered in Downers Grove, Illinois.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1,001 – 5,000
- Estimated revenue: $1K – $10K
- Total funding: $6.3M
- Funding stage: M&A
- Last round: Series Unknown (Nov 2018)
- Website: genetxbio.com
- Phone: (630) 639-7271
Industries & Categories
Biotechnology, Life Science, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/genetx-biotherapeutics-66835 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.